AJANTA PHARMA
Back to Cashflow Statement
|
AJANTA PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-68 Cr | ₹47 Cr | ₹-201 Cr | ₹124 Cr | ₹28 Cr |
What is the latest Net Cash Inflow / Outflow ratio of AJANTA PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-68 Cr |
| Mar2025 | ₹47 Cr |
| Mar2024 | ₹-201 Cr |
| Mar2023 | ₹124 Cr |
| Mar2022 | ₹28 Cr |
How is Net Cash Inflow / Outflow of AJANTA PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-68 Cr | Negative | |
| Mar2025 | ₹47 Cr | Positive | |
| Mar2024 | ₹-201 Cr | Negative | |
| Mar2023 | ₹124 Cr | 345.56 | |
| Mar2022 | ₹28 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹43,400.0 Cr | 0.1% | 5.9% | 22.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -2.3% | 3% | 12.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | 2.9% | 22.7% | 25.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -2.7% | 2% | 33.9% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.1% | 3% | -7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 2.4% | -12.9% | -9.1% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | 0.1% |
5.9% |
22.8% |
| SENSEX | 1.3% |
1% |
-2.9% |
You may also like the below Video Courses